1206 related articles for article (PubMed ID: 17402879)
21. Phosphate elimination in modalities of hemodialysis and peritoneal dialysis.
Kuhlmann MK
Blood Purif; 2010; 29(2):137-44. PubMed ID: 20093819
[TBL] [Abstract][Full Text] [Related]
22. Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis.
Gerdemann A; Lemke HD; Nothdurft A; Heidland A; Münch G; Bahner U; Schinzel R
Clin Nephrol; 2000 Oct; 54(4):276-83. PubMed ID: 11076103
[TBL] [Abstract][Full Text] [Related]
23. [Kt calculation as a quality indicator of haemodialysis adequacy].
Molina Núñez M; Roca Meroño S; de Alarcón Jiménez RM; García Hernández MA; Jimeno Griño C; Alvarez Fernández GM; Navarro Parreño MJ; Pérez Silva FM
Nefrologia; 2010; 30(3):331-6. PubMed ID: 20514099
[TBL] [Abstract][Full Text] [Related]
24. The effect of high-flux hemodialysis on renal anemia.
Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M
J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038
[TBL] [Abstract][Full Text] [Related]
25. Middle molecule removal in low-flux polysulfone dialyzers: impact of flows and surface area on whole-body and dialyzer clearances.
Eloot S; de Vos JY; de Vos F; Hombrouckx R; Verdonck P
Hemodial Int; 2005 Oct; 9(4):399-408. PubMed ID: 16219061
[TBL] [Abstract][Full Text] [Related]
26. Association between phosphate removal and markers of bone turnover in haemodialysis patients.
Albalate M; de la Piedra C; Fernández C; Lefort M; Santana H; Hernando P; Hernández J; Caramelo C
Nephrol Dial Transplant; 2006 Jun; 21(6):1626-32. PubMed ID: 16490746
[TBL] [Abstract][Full Text] [Related]
27. Dialyzer membrane permeability and survival in hemodialysis patients.
Chauveau P; Nguyen H; Combe C; Chêne G; Azar R; Cano N; Canaud B; Fouque D; Laville M; Leverve X; Roth H; Aparicio M;
Am J Kidney Dis; 2005 Mar; 45(3):565-71. PubMed ID: 15754279
[TBL] [Abstract][Full Text] [Related]
28. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
[TBL] [Abstract][Full Text] [Related]
29. [Kt as control and follow-up of the dose at a hemodialysis unit].
Maduell F; Vera M; Serra N; Collado S; Carrera M; Fernández A; Arias M; Blasco M; Burgadá E; Cases A; Campistol JM
Nefrologia; 2008; 28(1):43-7. PubMed ID: 18336130
[TBL] [Abstract][Full Text] [Related]
30. Acetate free biofiltration (AFB): from theory to clinical results.
Galli G; Panzetta G
Clin Nephrol; 1998 Jul; 50(1):28-37. PubMed ID: 9710344
[TBL] [Abstract][Full Text] [Related]
31. [On-line sequential hemodiafiltration (HDF-OL-S): a new therapeutic option].
Kanter J; Puerta MC; García RP; Gómez JM; Jofré R; Rodríguez PB
Nefrologia; 2008; 28(4):433-8. PubMed ID: 18662152
[TBL] [Abstract][Full Text] [Related]
32. Clinical use of high-efficiency hemodialysis treatments: long-term assessment.
Bosch JP; Lew SQ; Barlee V; Mishkin GJ; von Albertini B
Hemodial Int; 2006 Jan; 10(1):73-81. PubMed ID: 16441831
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with urea reduction ratio in acute renal failure.
Liangos O; Rao M; Ruthazer R; Balakrishnan VS; Modi G; Pereira BJ; Jaber BL
Artif Organs; 2004 Dec; 28(12):1076-81. PubMed ID: 15554935
[TBL] [Abstract][Full Text] [Related]
34. Phosphate Removal During Long Nocturnal Hemodialysis/Hemodiafiltration: A Study With Total Dialysate Collection.
Zupančič T; Ponikvar R; Gubenšek J; Buturović-Ponikvar J
Ther Apher Dial; 2016 Jun; 20(3):267-71. PubMed ID: 27312913
[TBL] [Abstract][Full Text] [Related]
35. Use of hemodiafiltration to enhance delivered dialysis.
Wei SS; Paganini EP; Cressman MD; Wright E
ASAIO J; 1994; 40(4):977-80. PubMed ID: 7858335
[TBL] [Abstract][Full Text] [Related]
36. Phosphate removal model: an observational study of low-flux dialyzers in conventional hemodialysis therapy.
Wang M; Li H; Liao H; Yu Y; You L; Zhu J; Huang B; Yuan L; Hao C; Chen J
Hemodial Int; 2012 Jul; 16(3):363-76. PubMed ID: 22360645
[TBL] [Abstract][Full Text] [Related]
37. Washout of water-soluble vitamins and of homocysteine during haemodialysis: effect of high-flux and low-flux dialyser membranes.
Heinz J; Domröse U; Westphal S; Luley C; Neumann KH; Dierkes J
Nephrology (Carlton); 2008 Oct; 13(5):384-9. PubMed ID: 18518942
[TBL] [Abstract][Full Text] [Related]
38. Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance.
Mudge DW; Rogers R; Hollett P; Law B; Reiger K; Petrie JJ; Price L; Johnson DW; Campbell SB; Isbel NM; Sullivan M; Hawley CM
Nephrol Dial Transplant; 2005 Oct; 20(10):2178-85. PubMed ID: 16030045
[TBL] [Abstract][Full Text] [Related]
39. The faster potassium-lowering effect of high dialysate bicarbonate concentrations in chronic haemodialysis patients.
Heguilén RM; Sciurano C; Bellusci AD; Fried P; Mittelman G; Rosa Diez G; Bernasconi AR
Nephrol Dial Transplant; 2005 Mar; 20(3):591-7. PubMed ID: 15687112
[TBL] [Abstract][Full Text] [Related]
40. Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure.
Lonnemann G; Bechstein M; Linnenweber S; Burg M; Koch KM
Kidney Int Suppl; 1999 Nov; (72):S84-7. PubMed ID: 10560813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
